FDA approves kallikrein inhibitor to treat hereditary angioedema

Title
FDA approves kallikrein inhibitor to treat hereditary angioedema
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
Volume 67, Issue 2, Pages 93-93
Publisher
American Society of Health System Pharmacists
Online
2010-01-12
DOI
10.2146/news100005

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started